ARCHIVES

ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic.

This article is from The Cancer Letter archive.

Vol. 36 No. 13 | April 9, 2010

Download PDF Visit The Full Archive

Related Articles

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

March 30, 2012

Taxotere Encouraging, CPT-11, Other Agents Entering Trials; Chabner

July 10, 1992

Collins Sworn In As NIH Director

September 4, 2009

Nine More state To Pay For Cancer Treatment Of CDC-Screened Women.

September 7, 2001

In Brief: Ahoy! It’s “Admiral Rick”

April 2, 1999

Editorial: A Record-Breaking Year for The Cancer Letter

December 19, 2014